Invention Grant
US08110352B2 Method of diagnosing and treating cancer using B-catenin splice variants
有权
使用B-连环蛋白剪接变体诊断和治疗癌症的方法
- Patent Title: Method of diagnosing and treating cancer using B-catenin splice variants
- Patent Title (中): 使用B-连环蛋白剪接变体诊断和治疗癌症的方法
-
Application No.: US11883694Application Date: 2006-02-10
-
Publication No.: US08110352B2Publication Date: 2012-02-07
- Inventor: Mark J. Roth , Konrad Huppi
- Applicant: Mark J. Roth , Konrad Huppi
- Applicant Address: US DC Washington
- Assignee: The United States of America as represented by the Secretary, Department of Health & Human Services
- Current Assignee: The United States of America as represented by the Secretary, Department of Health & Human Services
- Current Assignee Address: US DC Washington
- Agency: Edwards Wildman Palmer LLP
- Agent Peter F. Corless; Christine C. O'Day
- International Application: PCT/US2006/005032 WO 20060210
- International Announcement: WO2006/086772 WO 20060817
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574
Abstract:
The invention relates to method of diagnosing and treating cancer, in particular β-catenin related cancers. The invention further relates to methods of identifying CTNNB1 related cancer CTNNB1 therapeutics.
Public/Granted literature
- US20090111762A1 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS Public/Granted day:2009-04-30
Information query
